Global pharma major Lupin Limited announced the launch United States Food and Drug Administration (FDA) approved droxidopa capsules, 100 mg, 200 mg, and 300 mg.
Drug major Aurobindo Pharma NSE 1.56 % on Friday said it has received final approval from the US health regulator to manufacture and market Droxidopa capsules, used to treat dizziness and lightheadedness. The approved product is a generic version of Lundbeck NA Ltd's Northera capsules.
Tris pharma`s Generic Droxidopa Receives Approval In US
Tasman Pharma Generic Droxidopa Receives Approval In US
Sun Pharm`s Generic Droxidopa Receives Tentative Approval In US
Zydus Cadila, an innovative, global pharmaceutical company, has received tentative approval from the US FDA to market droxidopa capsules, (US RLD: Northera) in the strengths of 100 mg, 200 mg, and 300 mg.
Rising demand for Lundbeck’s four key products enabled the company to narrowly beat analyst sales expectations in the second quarter.